Arrowhead Pharmaceuticals Presents Preclinical Data on New RNAi-Based Obesity Program ARO-INHBE
Go back to Arrowhead Pharmaceuticals Presents Preclinical Data on New RNAi-Based Obesity Program ARO-INHBE| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 82.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.85 | 52 Week High | $8.22 | |||
| Open | $82.85 | 52 Week Low | $3.07 | |||
| Day High | $82.85 | P/E | N/A | |||
| Day Low | $82.85 | EPS | $-1.30 | |||
| Volume | 13 | |||||
